|o||Preliminary Proxy Statement|
|o||Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))|
|o||Definitive Proxy Statement|
|þ||Definitive Additional Materials|
|o||Soliciting Material Pursuant to §240.14a-12|
|þ||No fee required.|
|o||Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.|
|(1)||Title of each class of securities to which transaction applies:
|(2)||Aggregate number of securities to which transaction applies:|
|(3)||Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):|
|(4)||Proposed maximum aggregate value of transaction:|
|(5)||Total fee paid:|
|o||Fee paid previously with preliminary materials.|
|o||Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.|
|(1)||Amount Previously Paid:|
|(2)||Form, Schedule or Registration Statement No.:|
For holders as of:
|March 25, 2011|
Date: May 19, 2011
|Time: 10:00 AM PDT|
10210 Genetic Center Drive
San Diego, California 92121
|1) BY INTERNET:||www.proxyvote.com|
|2) BY TELEPHONE:||1-800-579-1639|
|3) BY E-MAIL*:||firstname.lastname@example.org|
|* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow è XXXX XXXX XXXX (located on the following page) in the subject line.|
|1.|| Election of Directors
|2||To approve the amendment and
The 2003 Incentive Award Plan of Gen-Probe Incorporated.
Advisory vote on the compensation of the named executive officers of Gen-Probe Incorporated.
Advisory vote on the frequency of future advisory votes on the compensation of the named executive officers of Gen-Probe Incorporated.
To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of Gen-Probe Incorporated for the fiscal year ending December 31, 2011.